SCHEMBL7965995

SCHEMBL7965995

O=C(O)CC(O)(CC(=O)OC1(c2cncc3ccccc23)CCN(CCC(O)Oc2cc(F)c(F)c3c2CCC3)CC1)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citric Acid SCHEMBL7965990 0.79 HTR1A (0.40)
Citric Acid SCHEMBL7965989 0.77 ESR1 (0.30)
SCHEMBL7965779 0.71 ITGA4 (0.33)
SCHEMBL7963764 0.64 MEN1 (0.35)
SCHEMBL7967126 0.64 ABCB1 (0.39)
SCHEMBL7965345 0.63 SLC6A1 (0.34)
Bromide SCHEMBL7965944 0.63 OPRM1 (0.36)
SCHEMBL7962999 0.63 OPRL1 (0.40)
SCHEMBL7966082 0.60 KDM4E (0.48)
SCHEMBL7963269 0.60 SLC6A2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed